These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 28807910)

  • 1. 24-Hour Pharmacokinetic Relationships for Vancomycin and Novel Urinary Biomarkers of Acute Kidney Injury.
    O'Donnell JN; Rhodes NJ; Lodise TP; Prozialeck WC; Miglis CM; Joshi MD; Venkatesan N; Pais G; Cluff C; Lamar PC; Briyal S; Day JZ; Gulati A; Scheetz MH
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28807910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Twenty-four hour pharmacokinetic relationships for intravenous vancomycin and novel urinary biomarkers of acute kidney injury in a rat model.
    Avedissian SN; Pais GM; O'Donnell JN; Lodise TP; Liu J; Prozialeck WC; Joshi MD; Lamar PC; Becher L; Gulati A; Hope W; Scheetz MH
    J Antimicrob Chemother; 2019 Aug; 74(8):2326-2334. PubMed ID: 31065686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Vancomycin Exposures Associated with Elevations in Novel Urinary Biomarkers of Acute Kidney Injury in Vancomycin-Treated Rats.
    Rhodes NJ; Prozialeck WC; Lodise TP; Venkatesan N; O'Donnell JN; Pais G; Cluff C; Lamar PC; Neely MN; Gulati A; Scheetz MH
    Antimicrob Agents Chemother; 2016 Oct; 60(10):5742-51. PubMed ID: 27431226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative Performance of Urinary Biomarkers for Vancomycin-Induced Kidney Injury According to Timeline of Injury.
    Pais GM; Avedissian SN; O'Donnell JN; Rhodes NJ; Lodise TP; Prozialeck WC; Lamar PC; Cluff C; Gulati A; Fitzgerald JC; Downes KJ; Zuppa AF; Scheetz MH
    Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 30988153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Pharmacodynamic-Toxicodynamic Relationship of AUC and
    Avedissian SN; Pais G; Liu J; O'Donnell JN; Lodise TP; Neely M; Prozialeck WC; Lamar PC; Becher L; Scheetz MH
    Antimicrob Agents Chemother; 2021 Feb; 65(3):. PubMed ID: 33318004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal biomarkers predict nephrotoxicity after paraquat.
    Wunnapuk K; Liu X; Peake P; Gobe G; Endre Z; Grice JE; Roberts MS; Buckley NA
    Toxicol Lett; 2013 Oct; 222(3):280-8. PubMed ID: 23954200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kidney biomarkers in MCPA-induced acute kidney injury in rats: reduced clearance enhances early biomarker performance.
    Wunnapuk K; Liu X; Gobe GC; Endre ZH; Peake PW; Grice JE; Roberts MS; Buckley NA
    Toxicol Lett; 2014 Mar; 225(3):467-78. PubMed ID: 24480514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of humanized vancomycin infusion on kidney function and kidney injury in a translational rat model.
    Chang J; Pais GM; Jubrail R; Engel PL; Scheetz MH
    Int J Antimicrob Agents; 2024 May; 63(5):107118. PubMed ID: 38417707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glomerular Function and Urinary Biomarker Changes between Vancomycin and Vancomycin plus Piperacillin-Tazobactam in a Translational Rat Model.
    Chang J; Pais GM; Valdez K; Marianski S; Barreto EF; Scheetz MH
    Antimicrob Agents Chemother; 2022 Mar; 66(3):e0213221. PubMed ID: 35007142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutrophil gelatinase-associated lipocalin is a better biomarker than cystatin C for the prediction of imminent acute kidney injury in critically ill patients.
    Yegenaga I; Kamis F; Baydemir C; Erdem E; Celebi K; Eren N; Baykara N
    Ann Clin Biochem; 2018 Mar; 55(2):190-197. PubMed ID: 28142264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic performance of urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin for acute kidney injury in an obstructive nephropathy patient.
    Xue W; Xie Y; Wang Q; Xu W; Mou S; Ni Z
    Nephrology (Carlton); 2014 Apr; 19(4):186-94. PubMed ID: 24165570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Vancomycin Loading Doses and Dose Escalation on Glomerular Function and Kidney Injury Biomarkers in a Translational Rat Model.
    Chang J; Pais GM; Engel PL; Klimek P; Marianski S; Valdez K; Scheetz MH
    Antimicrob Agents Chemother; 2023 Feb; 67(2):e0127622. PubMed ID: 36648224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary calprotectin, kidney injury molecule-1, and neutrophil gelatinase-associated lipocalin for the prediction of adverse outcome in pediatric acute kidney injury.
    Westhoff JH; Seibert FS; Waldherr S; Bauer F; Tönshoff B; Fichtner A; Westhoff TH
    Eur J Pediatr; 2017 Jun; 176(6):745-755. PubMed ID: 28409285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of obesity and sex on antimicrobial pharmacokinetics and acute kidney injury: validation of a preclinical model.
    Pai MP; Chen WZ; Garba A; Cui H; Zaffo B; El-Fawal HA; Mousa SA
    Antimicrob Agents Chemother; 2013 Feb; 57(2):716-22. PubMed ID: 23147732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative profile of commercially available urinary biomarkers in preclinical drug-induced kidney injury and recovery in rats.
    Rouse RL; Zhang J; Stewart SR; Rosenzweig BA; Espandiari P; Sadrieh NK
    Kidney Int; 2011 Jun; 79(11):1186-97. PubMed ID: 21150870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cystatin C and neutrophil gelatinase-associated lipocalin: biomarkers for acute kidney injury after congenital heart surgery.
    Seitz S; Rauh M; Gloeckler M; Cesnjevar R; Dittrich S; Koch AM
    Swiss Med Wkly; 2013; 143():w13744. PubMed ID: 23348800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population pharmacokinetics of vancomycin in critically ill patients receiving prolonged intermittent renal replacement therapy.
    Economou CJP; Kielstein JT; Czock D; Xie J; Field J; Richards B; Tallott M; Visser A; Koenig C; Hafer C; Schmidt JJ; Lipman J; Roberts JA
    Int J Antimicrob Agents; 2018 Aug; 52(2):151-157. PubMed ID: 29526606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An exploratory evaluation of the utility of transcriptional and urinary kidney injury biomarkers for the prediction of aristolochic acid-induced renal injury in male rats.
    Fuchs TC; Mally A; Wool A; Beiman M; Hewitt P
    Vet Pathol; 2014 May; 51(3):680-94. PubMed ID: 23912714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subclinical chronic kidney disease modifies the diagnosis of experimental acute kidney injury.
    Succar L; Pianta TJ; Davidson T; Pickering JW; Endre ZH
    Kidney Int; 2017 Sep; 92(3):680-692. PubMed ID: 28476556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose, duration, and animal sex predict vancomycin-associated acute kidney injury in preclinical studies.
    O'Donnell JN; Rhodes NJ; Miglis CM; Catovic L; Liu J; Cluff C; Pais G; Avedissian S; Joshi MD; Griffin B; Prozialeck W; Gulati A; Lodise TP; Scheetz MH
    Int J Antimicrob Agents; 2018 Feb; 51(2):239-243. PubMed ID: 28803934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.